Chatziralli I, Papadakou P, Dimitriou E, Kazantzis D, Kapsis P, Theodossiadis G, Papathanassiou M, Theodossiadis P. The effect of intravitreal anti-vascular endothelial growth factor injections on corneal endothelium in patients with diabetic macular oedema. Cutaneous and Ocular Toxicology. 2021:1–7.

Chatziralli I, Theodossiadis G, Chatzirallis A, Dimitriou E, Parikakis E, Parikakis E, Theodossiadis P. Evolution of macular microvasculature and retinal layers alterations in patients with macula off retinal detachment after vitrectomy. European Journal of Ophthalmology. 2021:1120672121992984.

Chatziralli I, Machairoudia G, Kazantzis D, Theodossiadis G, Theodossiadis P. Inverted internal limiting membrane flap technique for myopic macular hole: A meta-analysis. Survey of Ophthalmology. 2021.

Chatzirallis A, Varaklioti A, Sergentanis TN, Theodossiadis P, Chatziralli I. Quality of Life among Patients with Retinal Vein Occlusion: A Case-Control Study. In: Seminars in Ophthalmology. Taylor & Francis; 2021. pp. 1–7.

Zisimopoulos A, Klavdianou O, Theodossiadis P, Chatziralli I. The role of microbiome in age-related macular degeneration: A review of the literature. Ophthalmologica. 2021.

Chatziralli I, Chatzirallis A, Kazantzis D, Dimitriou E, Machairoudia G, Theodossiadis G, Parikakis E, Theodossiadis P. Predictive factors for long-term postoperative visual outcome in patients with macula-off rhegmatogenous retinal detachment treated with vitrectomy. Ophthalmologica. 2021.

Chatziralli I, Kazantzis D, Theodossiadis G, Theodossiadis P, Sergentanis TN. Retinal layers changes in patients with diabetic macular edema treated with intravitreal anti-VEGF agents: long-term outcomes of a spectral-domain OCT study. Ophthalmic Research. 2021;64:230–236.

Chatziralli E, Kabanarou S, Dimitriou E, Smoustopoulos G, Theodossiadis G, Bontzos G, Theodossiadis P. Early or late switch to intravitreal dexamethasone implant in patients with retinal vein occlusion and poor response to anti-VEGF agents?. Investigative Ophthalmology & Visual Science. 2020;61:1301–1301.

James SL, Castle CD, Dingels ZV, Fox JT, Hamilton EB, Liu Z, Roberts NLS, Sylte DO, Henry NJ, LeGrand KE, et al. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017. Injury Prevention. 2020;26:i96–i114.

Theodossiadis G, Theodossiadis P, Chatziralli I. The impact of scleral buckling technique application in diminishing high myopia. Graefe's Archive for Clinical and Experimental Ophthalmology= Albrecht von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie. 2020.

Dimitriou E, Theodossiadis P, Chatzirallis A, Kazantzis D, Theodossiadis G, Chatziralli E. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: Long-term outcomes in real-life data. Investigative Ophthalmology & Visual Science. 2020;61:3305–3305.

Chatziralli I, Dimitriou E, Xirou T, Kabanarou SA, Theodossiadis G, Theodossiadis P, others. Optical coherence tomography biomarkers as predictive factors for postoperative visual acuity in patients with epiretinal membrane treated with vitrectomy. Oman Journal of Ophthalmology. 2020;13:136.

Ragkousis A, Kozobolis V, Kabanarou S, Bontzos G, Mangouritsas G, Heliopoulos I, Chatziralli I. Vessel Density around Foveal Avascular Zone as a Potential Imaging Biomarker for Detecting Preclinical Diabetic Retinopathy: An Optical Coherence Tomography Angiography Study. In: Seminars in Ophthalmology. Vol. 35. Taylor & Francis; 2020. pp. 316–323.

Amato A, Nadin F, Borghesan F, Cicinelli MV, Chatziralli I, Sadiq S, Mirza R, Bandello F. Widefield Optical Coherence Tomography Angiography in Diabetic Retinopathy. Journal of Diabetes Research. 2020;2020.

James SL, Castle CD, Dingels ZV, Fox JT, Hamilton EB, Liu Z, Roberts NLS, Sylte DO, Bertolacci GJ, Cunningham M, et al. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study. Injury Prevention. 2020;26:i125–i153.

Chatziralli I, Theodossiadis G, Parikakis E, Chatzirallis A, Dimitriou E, Theodossiadis P. Inner retinal layers’ alterations and microvasculature changes after vitrectomy for rhegmatogenous retinal detachment. International Ophthalmology. 2020;40:3349–3356.

Kabanarou SA, Bontzos G, Xirou T, Kapsala Z, Dimitriou E, Theodossiadis P, Chatziralli I. Multimodal imaging for the assessment of geographic atrophy in patients with ‘foveal’and ‘no foveal’sparing. Ophthalmic Research. 2020.

Faes L, Rosenblatt A, Schwartz R, Touhami S, Ventura CV, Chatziralli IP, Ruiz-Medrano J, Vogt D, Savastano A, Ruiz-Garcia H, et al. Overcoming barriers of retinal care delivery during a pandemic—attitudes and drivers for the implementation of digital health: a global expert survey. British Journal of Ophthalmology. 2020.

Chatziralli I, Karamaounas A, Dimitriou E, Kazantzis D, Theodossiadis G, Kozobolis V, Theodossiadis P. Peripapillary Retinal Nerve Fiber Layer Changes in Patients with Diabetes Mellitus: A Case-control Study. In: Seminars in Ophthalmology. Vol. 35. Taylor & Francis; 2020. pp. 257–260.

Theodossiadis G, Theodossiadis P, Chatziralli I. Thoughts and Challenges for the Current Treatment of Optic Disc Pit Maculopathy. In: Seminars in Ophthalmology. Vol. 35. Taylor & Francis; 2020. pp. 232–236.

Chatziralli I, Ventura CV, Touhami S, Reynolds R, Nassisi M, Weinberg T, Pakzad-Vaezi K, Anaya D, Mustapha M, Plant A, et al. Transforming ophthalmic education into virtual learning during COVID-19 pandemic: a global perspective. Eye. 2020:1–8.

Chatziralli I, Theodossiadis G, Dimitriou E, Kazantzis D, Theodossiadis P. Association between the patterns of diabetic macular edema and photoreceptors’ response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study. International Ophthalmology. 2020;40:2441–2448.

Papadakou P, Chatziralli I, Papathanassiou M, Lambadiari V, Siganos CS, Theodossiadis P, Kozobolis V. The Effect of Diabetes Mellitus on Corneal Endothelial Cells and Central Corneal Thickness: A Case-Control Study. Ophthalmic research. 2020;63:550–554.

Chatziralli I, Dimitriou E, Theodossiadis G, Kazantzis D, Theodossiadis P. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study. Acta Diabetologica. 2020;57:1219–1225.

Kabanarou SA, Xirou T, Boutouri E, Gkizis I, Vasilias D, Bontzos G, Chatziralli I. Pre-operative intravitreal dexamethasone implant in patients with refractory diabetic macular edema undergoing cataract surgery. Scientific reports. 2020;10:1–6.

Dong X, Liu J, Bu J. Response to letter “The impact of scleral buckling technique application in diminishing high myopia”. Graefe's Archive for Clinical and Experimental Ophthalmology. 2020:1–1.

Chatziralli I, Dimitriou E, Theodossiadis G, Kazantzis D, Alonistiotis D, Theodossiadis P. Efficacy of intravitreal dexamethasone implant for the treatment of macular oedema after pars plana vitrectomy for rhegmatogenous retinal detachment: long-term outcomes. Cutaneous and ocular toxicology. 2020;39:25–30.

Chatziralli I. The impact of LEAVO study in Greece. 2020.

Chatziralli I, Dimitriou E, Theodossiadis G, Bourouki E, Bagli E, Kitsos G, Theodossiadis P. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study. International ophthalmology. 2020;40:841–847.

Garnavou-Xirou C, Xirou T, Gkizis I, Kabanarou SA, Dimitriou E, Theodossiadis P, Chatziralli I. The role of disorganization of retinal inner layers as predictive factor of postoperative outcome in patients with epiretinal membrane. Ophthalmic research. 2020;63:13–17.

Chatziralli IP, Sivaprasad S. Anti-Vascular Endothelial Growth Factor Therapy and Cardiovascular Disease Risk. In: Diabetic Retinopathy and Cardiovascular Disease. Vol. 27. Karger Publishers; 2019. pp. 100–105.

Bontzos G, Garnavou-Xirou C, Xirou T, Gkizis I, Kabanarou S, Chatziralli I. Do macular OCT-A measures correlate with functional outcomes in diabetic patients?. Acta Ophthalmologica. 2019;97.

Karagiannis D, Parikakis E, Kontomichos L, Batsos G, Chatziralli I. The effect of eplerenone in chronic central serous chorioretinopathy refractory to photodynamic therapy. In: Seminars in ophthalmology. Vol. 34. Taylor & Francis; 2019. pp. 436–441.

Chatziralli I, Dimitriou E, Chatzirallis A, Aissopou E, Theodossiadis P. Efficacy and safety of Resvega in diabetic macular edema: preliminary results of a pilot study. Acta Ophthalmologica. 2019;97.

Chatziralli I, Theodossiadis G, Dimitriou E, Kazantzis D, Theodossiadis P. Macular edema after successful pars plana vitrectomy for rhegmatogenous retinal detachment: factors affecting edema development and considerations for treatment. Ocular immunology and inflammation. 2019:1–6.

Chatziralli I, Theodossiadis P, Theodossiadis G. New observations regarding the assessment of cilioretinal arteries coexistence with optic disc pit. In: Seminars in ophthalmology. Vol. 34. Taylor & Francis; 2019. pp. 375–379.

Chatziralli I. Optical coherence tomography biomarkers for idiopathic epiretinal membrane after pars plana vitrectomy. Acta Ophthalmologica. 2019;97.

Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, Culpepper WJ, Dorsey E, Elbaz A, Ellenbogen RG, et al. Global, regional and national burden of neurological. Disorders, 1990-2016: a systematic analysis for the Global Study of the burden of disease 2016. 2019.

Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, Culpepper WJ, Dorsey RE, Elbaz A, Ellenbogen RG, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019;18:459–480.

Peponis V, Kontomichos L, Chatziralli I, Kontadakis G, Parikakis E. Late onset corneal haze after corneal cross-linking for progressive keratoconus. American journal of ophthalmology case reports. 2019;14:64–66.

Sfiniadaki E, Tsiara I, Theodossiadis P, Chatziralli I. Ocular manifestations of granulomatosis with polyangiitis: a review of the literature. Ophthalmology and therapy. 2019;8:227–234.

Chatziralli I, Dimitriou E, Theodossiadis G, Chatzirallis A, Kazantzis D, Theodossiadis P. Treatment of macular edema after pars plana vitrectomy for idiopathic epiretinal membrane using intravitreal dexamethasone implant: long-term outcomes. Ophthalmologica. 2019;242:16–21.

Chatzara A, Chronopoulou I, Theodossiadis G, Theodossiadis P, Chatziralli I. XEN implant for glaucoma treatment: a review of the literature. In: Seminars in ophthalmology. Vol. 34. Taylor & Francis; 2019. pp. 93–97.

Chatziralli I, Saitakis G, Dimitriou E, Chatzirallis A, Stoungioti S, Theodossiadis G, Theodossiadis P. Angioid streaks: a comprehensive review from pathophysiology to treatment. Retina. 2019;39:1–11.

Rouvas A, Chatziralli I, Androu A, Mpougatsou P, Alonistiotis D, Douvali M, Kabanarou SA, Theodossiadis P. Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration. International ophthalmology. 2019;39:431–440.

Figueira J, Fletcher E, Massin P, Silva R, Bandello F, Midena E, Varano M, Sivaprasad S, Eleftheriadis H, Menon G, et al. Ranibizumab plus panretinal photocoagulation versus panretinal photocoagulation alone for high-risk proliferative diabetic retinopathy (PROTEUS study). Ophthalmology. 2018;125:691–700.

Chatziralli I, Kabanarou S, Parikakis E, CHATZIRALLIS A, Xirou T, Mitropoulos P. Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study. In: ACTA OPHTHALMOLOGICA. Vol. 96. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 21–21.

Chatziralli I, Dimitriou E, Saitakis G, CHATZIRALLIS A, Theodossiadis G, Theodossiadis P. Coexistence of diabetic retinopathy and age-related macular degeneration: epidemiology and management. In: ACTA OPHTHALMOLOGICA. Vol. 96. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 21–21.

Theodorou-Kanakari A, Karampitianis S, Karageorgou V, Kampourelli E, Kapasakis E, Theodossiadis P, Chatziralli I. Current and emerging treatment modalities for Leber’s hereditary optic neuropathy: a review of the literature. Advances in therapy. 2018;35:1510–1518.

Chatziralli I. Editorial-suboptimal response to intravitreal anti-VEGF treatment for patients with diabetic macular edema: is there any point in switching treatment. Eur Rev Med Pharmacol Sci. 2018;22:5047–50.

Chatziralli I, Vlachodimitropoulou A, Daoula C, Vrettou C, Galani E, Theodossiadis G, Theodossiadis P. Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature. International journal of retina and vitreous. 2018;4:1–5.

Chatziralli I, Dimitriou E, Kabanarou S, CHATZIRALLIS A, Xirou T, Theodossiadis G, Theodossiadis P. Fundus autofluorescence changes in diabetic retinopathy. In: ACTA OPHTHALMOLOGICA. Vol. 96. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 21–21.

Chatziralli I, Regan SO, Mohamed R, Talks J, Sivaprasad S. Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes. Eye. 2018;32:1523–1529.

Chatziralli I, Theodossiadis P, Theodossiadis GP. Optic disk pit maculopathy: current management strategies. Clinical Ophthalmology (Auckland, NZ). 2018;12:1417.

Moschos MM, Gouliopoulos NS, Kalogeropoulos C, Androudi S, Kitsos G, Ladas D, Tsatsos M, Chatziralli I. Psychological aspects and depression in patients with symptomatic keratoconus. Journal of ophthalmology. 2018;2018.

Xirou T, Garnavou-Xirou C, Kabanarou S, Gkizis I, Bitza P, Koutropoulou N, Kontou E, Chatziralli I. The role of disorganization of inner retinal layers as predictive factor in patients with epiretinal membrane. In: ACTA OPHTHALMOLOGICA. Vol. 96. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 139–139.

Chatziralli I, Theodossiadis G, Panagiotidis D, Pousoulidi P, Theodossiadis P. Choriocapillaris vascular density changes in patients with drusen: cross-sectional study based on optical coherence tomography angiography findings. Ophthalmology and therapy. 2018;7:101–107.

Zola M, Chatziralli I, Menon D, Schwartz R, Hykin P, Sivaprasad S. Evolution of fundus autofluorescence patterns over time in patients with chronic central serous chorioretinopathy. Acta ophthalmologica. 2018;96:e835–e839.

Chatziralli IP, Theodossiadis PG, Steel DHW. Internal limiting membrane peeling in macular hole surgery; why, when, and how?. Retina. 2018;38:870–882.

Chatziralli I, Theodossiadis P, Theodossiadis G, Asproudis I. Perspectives on diagnosis and management of adult idiopathic intracranial hypertension. Graefe's Archive for Clinical and Experimental Ophthalmology. 2018;256:1217–1224.

Moschos MM, Laios K, Androudi S, Ladas DS, Chatziralli IP. Anti-platelet effects of vitamin supplements in age-related macular degeneration: an in vitro study. Cutaneous and ocular toxicology. 2018;37:207–209.

Chatziralli I, Chatzipantelis A, Dimitriou E, Mpourouki E, Theodossiadis G, Theodossiadis P. Refractive changes after intravitreal ranibizumab injections for diabetic macular oedema. Clinical and Experimental Optometry. 2018;101:397–399.

Chatziralli IP. The role of glycemic control and variability in diabetic retinopathy. Diabetes Therapy. 2018;9:431–434.

Chatziralli I, Stavrakas P, Theodossiadis G, Ananikas K, Dimitriou E, Theodossiadis P. The impact of epiretinal membrane in neovascular age-related macular degeneration treatment: a spectral-domain optical coherence tomography study. In: Seminars in ophthalmology. Vol. 33. Taylor & Francis; 2018. pp. 651–656.

Chatziralli I, Theodossiadis G, Panagiotidis D, Pousoulidi P, Theodossiadis P. Choriocapillaris’ alterations in the presence of reticular pseudodrusen compared to drusen: study based on OCTA findings. International ophthalmology. 2018;38:1887–1893.

Moschos MM, Chatziralli IP. Evaluation of choroidal and retinal thickness changes in Parkinson’s disease using spectral domain optical coherence tomography. In: Seminars in ophthalmology. Vol. 33. Taylor & Francis; 2018. pp. 494–497.

Chatziralli I, Theodossiadis G, Chatzirallis A, Parikakis E, Mitropoulos P, Theodossiadis P. Ranibizumab for retinal vein occlusion: predictive factors and long-term outcomes in real-life data. Retina. 2018;38:559–568.

Xirou T, Kabanarou SA, Gkizis I, Garnavou-Xirou C, Velissaris S, Theodossiadis P, Chatziralli I. Chronic central serous chorioretinopathy-like maculopathy as atypical presentation of chorioretinal folds. Case reports in ophthalmology. 2017;8:568–573.

Chatziralli I, Theodossiadis G, Theodossiadis P. Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:1459–1460.

Chatziralli I, Theodossiadis G, Moschos MM, Mitropoulos P, Theodossiadis P. Ranibizumab vs. Aflibercept for Macular Edema due to Central Retinal Vein Occlusion. Ophthalmology Retina. 2017;1:355–356.

Moschos MM, Chatziralli I, Gazouli M, Brouzas D, Cennamo G, Eidenberger T, Forte R, Panzella L, Cesarano I, Napolitano A, et al. Acknowledgements to the Referees. Ophthalmic Research. 2017;58:243–243.

Moschos MM, Chatziralli I, Gazouli M, Brouzas D, Cennamo G, Eidenberger T, Forte R, Panzella L, Cesarano I, Napolitano A, et al. Contents Vol. 58, 2017. Ophthalmic Research. 2017;58:I–IV.

Chatziralli I, Theodossiadis P, Parikakis E, Dimitriou E, Xirou T, Theodossiadis G, Kabanarou SA. Dexamethasone intravitreal implant in diabetic macular edema: real-life data from a prospective study and predictive factors for visual outcome. Diabetes Therapy. 2017;8:1393–1404.

Garnavou-Xirou C, Xirou T, Kabanarou S, Gkizis I, Velissaris S, Chatziralli I. Eccentric macular hole after pars plana vitrectomy for epiretinal membrane without internal limiting membrane peeling: A case report. Ophthalmology and therapy. 2017;6:391–395.

Moschos MM, Chatziralli I, Gazouli M, Brouzas D, Cennamo G, Eidenberger T, Forte R, Panzella L, Cesarano I, Napolitano A, et al. Front & Back Matter. Ophthalmic Research. 2017;58.

Karagiannis D, Chatziralli I, Kaprinis K, Georgalas I, Parikakis E, Mitropoulos P. Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration. Clinical interventions in aging. 2017;12:1829.

Chatziralli IP, Sergentanis TN. Ocular gene therapy for neovascular AMD: a new era?. The Lancet. 2017;390:2139–2140.

Moschos MM, Chatziralli I, Brouzas D, Gazouli M. Bax and bcl2 gene polymorphisms in rhegmatogenous retinal detachment. Ophthalmic research. 2017;58:227–230.

Halkiadakis I, Chatziralli I, Drakos E, Katzakis M, Skouriotis S, Patsea E, Mitropoulos P, Kandarakis A. Causes and management of small pupil in patients with cataract. Oman journal of ophthalmology. 2017;10:220.

Xirou T, Kabanarou S, Gkizis I, Garnavou-Xirou C, Velissaris S, Chatziralli I. Eccentric macular hole after pars plana vitrectomy for epiretinal membrane without internal limiting membrane peeling. Acta Ophthalmologica. 2017;95.

Gkizis I, Garnavou-Xirou C, Velissaris S, Kabanarou S, Chatziralli I, Kontou E, Xirou T. Enzymatic vitreolysis with ocriplasmin for symptomatic vitreomacular traction syndrome. Acta Ophthalmologica. 2017;95.

Xirou T, Chatziralli I. Ocriplasmin in the treatment of vitreomacular traction–for. Acta Ophthalmologica. 2017;95.

Chatziralli I, Theodossiadis G, Brouzas D, Emfietzoglou I, Theodossiadis P. Optical Coherence Tomography Evolution in a Case of X-Linked Juvenile Retinoschisis: 15 Years of Follow-Up. Case reports in ophthalmology. 2017;8:459–464.

Chatziralli I, Theodossiadis G, Kabanarou SA, Theodossiadis P. Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:2077–2078.

Chatziralli I, Chatzipantelis A, Dimitriou E, Mpourouki E, Saitakis G, Theodossiadis P. Refractive changes after anti-VEGF injections for diabetic macular edema. Acta Ophthalmologica. 2017;95.

Chatziralli I. Surgical management of diabetic macular edema–Against. Acta Ophthalmologica. 2017;95.

Chatziralli I, Theodossiadis P, Nicholson L, Steel D. Advances in Vitreoretinal Interface Disorders. 2017.

Chatziralli IP, Theodossiadis G, Dimitriadis P, Charalambidis M, Agorastos A, Migkos Z, Platogiannis N, Moschos MM, Theodossiadis P, Keryttopoulos P. The effect of vitamin E on oxidative stress indicated by serum malondialdehyde in insulin-dependent type 2 diabetes mellitus patients with retinopathy. The open ophthalmology journal. 2017;11:51.

Kabanarou SA, Xirou T, Mangouritsas G, Garnavou-Xirou C, Boutouri E, Gkizis I, Chatziralli I. Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration. Clinical interventions in aging. 2017;12:911.

Chatziralli I, Santarelli M, Patrao N, Nicholson L, Zola M, Rajendram R, Hykin P, Sivaprasad S. Identification of time point to best define ‘sub-optimal response’following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data. Eye. 2017;31:1594–1599.

Chatziralli I, Theodossiadis G, Brouzas D, Theodossiadis P. Incidence and evolution of subretinal precipitates in optic disc pit maculopathy. European journal of ophthalmology. 2017;27:769–773.

Chatziralli I, Theodossiadis G, Parikakis E, Mitropoulos PG, Theodossiadis P. Long-term anatomical and functional outcomes in patients with ischemic central retinal vein occlusion treated with anti-vascular endothelial growth factor agents. Ophthalmic research. 2017;58:203–208.

Chatziralli I, Sergentanis TN, Crosby-Nwaobi R, Winkley K, Eleftheriadis H, Ismail K, Amiel SA, Sivaprasad S. Model for risk-based screening of diabetic retinopathy in people with newly-diagnosed type 2 diabetes mellitus. Investigative ophthalmology & visual science. 2017;58:BIO99–BIO105.

Chatziralli I, Theodossiadis G, Kabanarou SA, Parikakis E, Xirou T, Mitropoulos P, Theodossiadis P. Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the RANIDEX study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:1899–1905.

Shin KU, Bae JH, Song SJ, Lee MY, Ozgonul C, Besirli CG, Bartov E, Marques FB, Alves C, Ribeiro I, et al. SIRCOVA-OFTARED Joined Congress Abstracts. Valencia (Spain), June 30-July 2, 2016: Abstracts. Ophthalmic Research. 2017;57:13–31.

Chatziralli I, Theodossiadis G, Douvali M, Rouvas AA, Theodossiadis P. Eccentric macular hole after pars plana vitrectomy for idiopathic macular hole: a case report. Case reports in ophthalmology. 2017;8:116–119.

Papastavrou VT, Chatziralli I, McHugh D. Gas Tamponade for Retinectomy in PVR-Related Retinal Detachments: A Retrospective Study. Ophthalmology and therapy. 2017;6:161–166.

Ramu J, Chatziralli I, Yang Y, Menon G, Bailey C, Eckstein M, Hykin P, Sivaprasad S. Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema. Patient preference and adherence. 2017;11:579.

Chatziralli I, Theodossiadis G, Moschos MM, Mitropoulos P, Theodossiadis P. Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:1093–1100.

Moschos MM, Chatziralli I, Sioziou A, Gazouli M. Receptor of advanced glycation end products gene polymorphism and primary open-angle glaucoma. Ophthalmic research. 2017;58:81–84.

Chatziralli I, Kabanarou SA, Parikakis E, Chatzirallis A, Xirou T, Mitropoulos P. Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study. Current Eye Research. 2017;42:1069–1073.

Chatziralli IP. The role of dyslipidemia control in the progression of diabetic retinopathy in patients with type 2 diabetes mellitus. Diabetes Therapy. 2017;8:209–212.

Chatziralli IP, Sergentanis TN, Sivaprasad S. The effect of vitreous on proliferative diabetic retinopathy and the response to panretinal photocoagulation. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:423.

Chatziralli IP, Sergentanis TN, Parikakis EA, Papazisis LE, Mitropoulos P, Moschos MM. The impact of non-steroidal anti-inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and therapy. 2017;6:133–140.

Chatziralli I, Maniatea A, Koubouni K, Parikakis E, Mitropoulos P. Intravitreal ranibizumab for retinal arterial macroaneurysm: long-term results of a prospective study. European journal of ophthalmology. 2017;27:215–219.

Chatziralli I, Mitropoulos PG, Niakas D, Labiris G. Thyroidopathy and age-related macular degeneration: is there any correlation. Biomedicine hub. 2017;2:1–3.

Chatziralli I, Theodossiadis G, Datseris I, Parikakis E, Theodossiadis P. Anatomical and Functional Changes in the Coexistence of Vitreomacular Traction and Epiretinal Membrane: A Spectral-Domain Optical Coherence Tomography Study. Ophthalmic research. 2017;57:54–59.

Chatziralli I, Theodossiadis G, Grigoropoulos V, Datseris I, Chatzirallis A, Theodossiadis P. Comparison of macular findings due to vitreomacular traction alone or in association with epiretinal membrane. European journal of ophthalmology. 2017;27:86–92.

Chatziralli I, Mitropoulos P, Parikakis E, Niakas D, Labiris G. Risk factors for poor quality of life among patients with age-related macular degeneration. In: Seminars in ophthalmology. Vol. 32. Taylor & Francis; 2017. pp. 772–780.

Chatziralli IP, Sharma PK, Sivaprasad S. Treatment modalities for idiopathic macular telangiectasia: an evidence-based systematic review of the literature. In: Seminars in ophthalmology. Vol. 32. Taylor & Francis; 2017. pp. 384–394.

Moschos MM, Chatziralli IP, Stamatakis G, Papakonstantinou VD, Tsatsos M, Demopoulos CA. In vitro effects of anti-glaucomatous eye drops on platelet-activating factor and its metabolism. In: Seminars in ophthalmology. Vol. 32. Taylor & Francis; 2017. pp. 198–203.

Chatziralli I, Theodossiadis G, Panagiotidis D, Emfietzoglou I, Grigoropoulos V, Theodossiadis P. Long-term changes of macular thickness after pars plana vitrectomy in optic disc pit maculopathy: a spectral-domain optical coherence tomography study. In: Seminars in ophthalmology. Vol. 32. Taylor & Francis; 2017. pp. 302–308.

Theodossiadis G, Chatziralli I, Theodossiadis P. Abnormal traction of the vitreous detected by swept-source optical coherence tomography is related to the maculopathy associated with optic disc pits. Graefe's Archive for Clinical and Experimental Ophthalmology. 2016;254:1857.

Chatziralli I, Theodossiadis P, Theodossiadis G. Current management of optic disc pit. Expert Review of Ophthalmology. 2016;11:361–366.

Moschos M, Nitoda E, Laios K, Chatziralli IP, Tsatsos M, others. Evaluation of the emotional status in patients with retinitis pigmentosa using PHQ-9 and Zung scores: is the depression common in retinitis pigmentosa?. J Clin Exp Ophthalmol. 2016;7:2.

Moschos MM, Nitoda E, Chatziralli IP, Panos GD, Demopoulos CA. Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study. Drug design, development and therapy. 2016;10:3977.

Moschos MM, Nitoda E, Laios K, Ladas DS, Chatziralli IP. Response to: Comment on “The Impact of Chronic Tobacco Smoking on Retinal and Choroidal Thickness in Greek Population”. Oxidative medicine and cellular longevity. 2016;2016.

Chatziralli IP, Sergentanis TN, Sivaprasad S. Hyperreflective foci as an independent visual outcome predictor in macular edema due to retinal vascular diseases treated with intravitreal dexamethasone or ranibizumab. Retina. 2016;36:2319–2328.

Theodossiadis GP, Chatziralli IP, Theodossiadis PG. Inverted internal limiting membrane insertion for macular hole–associated retinal detachment in high myopia. American journal of ophthalmology. 2016;165:206–207.

Chatziralli I, Theodossiadis G, Xanthopoulou P, Miligkos M, Sivaprasad S, Theodossiadis P. Ocriplasmin use for vitreomacular traction and macular hole: a meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications. Graefe's Archive for Clinical and Experimental Ophthalmology. 2016;254:1247–1256.

Chatziralli I, Sergentanis T, Zagouri F, Chrysikos D, Ladas I, Zografos GC, Moschos M. Ocular surface disease in breast cancer patients using aromatase inhibitors. The breast journal. 2016;22:561–563.

Nicholson L, Goh LY, Marshall E, Vazquez-Alfageme C, Chatziralli I, Clemo M, Hykin PG, Sivaprasad S. Posterior segment distortion in ultra-widefield imaging compared to conventional modalities. Ophthalmic Surgery, Lasers and Imaging Retina. 2016;47:644–651.

Chatziralli I, Nicholson L, Vrizidou E, Koutsiouki C, Menon D, Sergentanis TN, Citu MC, Hamilton R, Patel PJ, Hykin P, et al. Predictors of outcome in patients with neovascular age-related macular degeneration switched from ranibizumab to 8-weekly aflibercept. Ophthalmology. 2016;123:1762–1770.

Chatziralli IP, Theodossiadis GP, Parikakis E, Datseris I, Theodossiadis P. Complications of intravitreal ocriplasmin for vitreomacular traction and macular hole: a prospective spectral-domain optical coherence tomography study. Cutaneous and ocular toxicology. 2016;35:263–269.

Moschos MM, Nitoda E, Laios K, Ladas DS, Chatziralli IP. The impact of chronic tobacco smoking on retinal and choroidal thickness in Greek population. Oxidative Medicine and Cellular Longevity. 2016;2016.

Rouvas A, Chatziralli I, Androu A, Papakonstantinou S, Kouvari MS, Alonistiotis D, Theodossiadis P. Long-term anatomical and functional results in patients undergoing observation for idiopathic nontractional epiretinal membrane. European journal of ophthalmology. 2016;26:273–278.

Sivaprasad S, Bird A, Nitiahpapand R, Nicholson L, Hykin P, Chatziralli I, Consortium MUCLAMD, others. Perspectives on reticular pseudodrusen in age-related macular degeneration. Survey of ophthalmology. 2016;61:521–537.

Chatziralli IP, Sergentanis TN, Sivaprasad S. Prediction of regression of retinal neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology. 2016;254:1715–1721.

Chatziralli IP, Jaulim A, Chatzirallis A, Moschos MM. Subconjunctival haemorrhage as an indication of gastrointestinal bleeding. Clinical and Experimental Optometry. 2016;99:93–93.

Moschos MM, Gazouli M, Gatzioufas Z, Brouzas D, Nomikarios N, Sivaprasad S, Mitropoulos P, Chatziralli IP. Prevalence of the complement factor H and GSTM1 genes polymorphisms in patients with central serous chorioretinopathy. Retina. 2016;36:402–407.

Chatziralli I, Theodossiadis G, Parikakis E, Datseris I, Theodossiadis P. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2016;254:223–233.

Moschos MM, Chatziralli IP, Sergentanis T, Zagouri F, Chrysikos D, Ladas I, Zografos G. Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors. Cutaneous and ocular toxicology. 2016;35:13–20.

Chatziralli I, Theodossiadis G, Emfietzoglou I, Theodossiadis P. Intravitreal ranibizumab for choroidal neovascularization secondary to gyrate atrophy in a young patient: a multimodal imaging analysis. European journal of ophthalmology. 2015;25:e119–e122.

Chatziralli I, Nicholson L, Sivaprasad S, Hykin P. Intravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials. Expert opinion on biological therapy. 2015;15:1685–1697.

Moschos MM, Chatziralli IP, Tsatsos M. One-site versus two-site phacotrabeculectomy: a prospective randomized study. Clinical interventions in aging. 2015;10:1393.

Moschos MM, Nitoda E, Chatziralli IP, Gatzioufas Z, Koutsandrea C, Kitsos G. Assessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography study. Drug design, development and therapy. 2015;9:2993.

Crosby-Nwaobi R, Chatziralli I, Sergentanis T, Dew T, Forbes A, Sivaprasad S. Cross talk between lipid metabolism and inflammatory markers in patients with diabetic retinopathy. Journal of diabetes research. 2015;2015.

Moschos M, Chatzirallis A, Chatziralli I. Psychological aspects and depression in patients with retinitis pigmentosa. European journal of ophthalmology. 2015;25:459–462.

Chatziralli I, Sivaprasad S. Spectral domain optical coherence tomography evaluation of retinal neovascularization after panretinal photocoagulation in proliferative diabetic retinopathy. Investigative Ophthalmology & Visual Science. 2015;56:1801–1801.

Chatziralli IP, Parikakis EA, Mitropoulos PG. Undiagnosed patent foramen ovale as a rare cause for branch retinal artery occlusion. European journal of ophthalmology. 2015;25:e88–e90.

Theodossiadis GP, Chatziralli IP, Sergentanis TN, Datseris I, Theodossiadis PG. Evolution of vitreomacular adhesion to acute vitreofoveal separation with special emphasis on a traction-induced foveal pathology. A prospective study of spectral-domain optical coherence tomography. Graefe's Archive for Clinical and Experimental Ophthalmology. 2015;253:1425–1435.

Rouvas A, Nikita E, Chatziralli I, Ladas I, Androu A, Theodossiadis P. Long-term follow-up of standard photodynamic therapy with standardized small spot size for diffuse retinal pigment epitheliopathy. European journal of ophthalmology. 2015;25:229–234.

Theodossiadis GP, Chatziralli IP, Theodossiadis PG. Macular buckling in optic disc pit maculopathy in association with the origin of macular elevation: 13-year mean postoperative results. European journal of ophthalmology. 2015;25:241–248.

Chatziralli I, Douvali M, Theodossiadis P, Rouvas AA. Reply to the Comment by Ilhan et al. on Our Paper Entitled'Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema'. Ophthalmologica. 2015;233:116.

Sergentanis TN, Chatziralli IP. Sir, Methodological remarks concerning the recent meta-analysis on the effect of intravitral bevacizumab in central serous chorioretinopathy. Eye. 2015;29:978–985.

Mitropoulos PG, Chatziralli IP, Peponis VG, Drakos E, Parikakis EA. Intravitreal ranibizumab for the treatment of Irvine-Gass syndrome. Ocular immunology and inflammation. 2015;23:225–231.

Moschos MM, Kokolakis N, Gazouli M, Chatziralli IP, Droutsas D, Anagnou NP, Ladas ID. Polymorphism analysis of VSX1 and SOD1 genes in Greek patients with keratoconus. Ophthalmic genetics. 2015;36:213–217.

Moschos MM, Chatziralli IP, Kalogeropoulos C, Agapitos E, Koutsandrea C. Retinal toxicity of intravitreal rastuzumab in a rabbit model: preliminary results of an experimental study. Investigative Ophthalmology & Visual Science. 2014;55:2078–2078.

Douvali M, Chatziralli IP, Theodossiadis PG, Chatzistefanou KI, Giannakaki E, Rouvas AA. Effect of macular ischemia on intravitreal ranibizumab treatment for diabetic macular edema. Ophthalmologica. 2014;232:136–143.

Mitropoulos PG, Chatziralli IP, Parikakis EA, Peponis VG, Amariotakis GA, Moschos MM. Intravitreal ranibizumab for stage IV proliferative sickle cell retinopathy: a first case report. Case reports in ophthalmological medicine. 2014;2014.

Parikakis E, Chatziralli I, Stratos E, Peponis V, Karagiannis D, Tsiotra V, Mitropoulos P. Significant visual improvement after spontaneous resolution of longstanding macular detachment due to optic disc pit. Acta Ophthalmologica. 2014;92.

Moschos MM, Nitoda E, Chatziralli IP, Demopoulos CA. Age-related macular degeneration: pathogenesis, genetic background, and the role of nutritional supplements. Journal of Chemistry. 2014;2014.

Moschos MM, Chatziralli IP, Koutsandrea C. Intraocular lens power calculation in eyes with short axial length. Indian journal of ophthalmology. 2014;62:692.

Chatziralli I, Parikakis E, Peponis V, Tsiotra V, Mitropoulos P. Intravitreal ranibizumab for the treatment of irvine-gass syndrome. Acta Ophthalmologica. 2014;92.

Parikakis E, Chatziralli I, Stratos E, Peponis V, Karagiannis D, David G, Mitropoulos P. Long term results of toric intraocular lens implantation for correction of astigmatism in cataract patients with corneal ectasia. Acta Ophthalmologica. 2014;92.

Kokolakis NS, Gazouli M, Chatziralli IP, Koutsandrea C, Gatzioufas Z, Peponis VG, Droutsas KD, Kalogeropoulos C, Anagnou N, Miltsakakis D, et al. Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus. Ophthalmic genetics. 2014;35:226–228.

Parikakis EA, Chatziralli IP, Peponis VG, Karagiannis D, Stratos A, Tsiotra VA, Mitropoulos PG. Spontaneous Resolution ofLong-Standing Macular Detachment due to Optic Disc Pit with Significant Visual Improvement. Case reports in ophthalmology. 2014;5:104–110.

Chatziralli IP, Jaulim A, Peponis VG, Mitropoulos PG, Moschos MM. Branch retinal vein occlusion: treatment modalities: an update of the literature. In: Seminars in Ophthalmology. Vol. 29. Taylor & Francis; 2014. pp. 85–107.

Rouvas AA, Chatziralli IP, Ladas ID, Xanthopoulou V, Giannakaki E, Karamboula A, Galanis D, Datseris I, Alonistiotis D, Diamanti R, et al. The impact of financial crisis on central serous chorioretinopathy in Greece: is there any correlation?. European journal of ophthalmology. 2014;24:559–565.

Moschos MM, Chatziralli IP, Stamatakis G, Papakonstantinou VD, Demopoulos CA. In vitro effects of vitamin supplements on platelet-activating factor and its metabolism in age-related macular degeneration. Cutaneous and ocular toxicology. 2014;33:235–241.

Mitropoulos PG, Chatziralli IP, Peponis VG, Tsiotra VA, Parikakis EA. Photodynamic therapy for juxtapapillary retinal capillary hemangioma. Case reports in ophthalmological medicine. 2014;2014.

Chatziralli IP, Papazisis L, Sergentanis TN. Incomplete Gardner’s syndrome with blepharoptosis as the first symptom. International ophthalmology. 2014;34:301–303.

Tsimpida M, Chatziralli I, Ezra E, Reddy MA. Delayed diagnosis of occult ocular juvenile xanthogranuloma mimicking non-accidental injury. Eye. 2013;27:895–896.

Moschos MM, Chatziralli IP, Verriopoulos GV, Triglianos A, Ladas DS, Brouzas D. Correlation between optical coherence tomography and multifocal electroretinogram findings with visual acuity in retinitis pigmentosa. Clinical Ophthalmology (Auckland, NZ). 2013;7:2073.

Chatziralli I, Parikakis E, Peponis V, Maniatea A, Mitropoulos P. Risk factors for intraoperative floppy iris syndrome: One year prospective study. Acta Ophthalmologica. 2013;91.

Chatziralli IP, Sergentanis TN, Peponis VG, Papazisis LE, Moschos MM. Risk factors for poor vision-related quality of life among cataract patients. Evaluation of baseline data. Graefe's Archive for Clinical and Experimental Ophthalmology. 2013;251:783–789.

Parikakis EA, Chatziralli IP, Peponis VG, David G, Chalkiadakis S, Mitropoulos PG. Toric intraocular lens implantation for correction of astigmatism in cataract patients with corneal ectasia. Case reports in ophthalmology. 2013;4:219–228.

Moschos MM, Chatziralli IP, Koutsandrea C, Siasou G, Droutsas D. Assessment of the macula in keratoconus: an optical coherence tomography and multifocal electroretinography study. Ophthalmologica. 2013;229:203–207.

Jaulim A, Ahmed B, Khanam T, Chatziralli IP. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina. 2013;33:901–910.

Moschos MM, Chatziralli IP, Kalogeropoulos C, Georgountzos V, Agapitos E. Retinal toxicity of intravitreal trastuzumab in a rabbit model: preliminary results of an experimental study. Journal of ocular pharmacology and therapeutics. 2013;29:754–759.

Chatziralli I, Parikakis E, Peponis V, Tsiotra V, Mitropoulos P. Photodynamic therapy for juxtapapillary retinal capillary hemangioma: A case report. Acta Ophthalmologica. 2013;91.

Chatziralli VPIGP, Michail EPNCA, Katzakis C, Mitropoulos PG. Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report. 2012.

Moschos MM, Chatziralli EP, Sergentanis TN, Ladas I. Viscoat Versus Visthesia During Phacoemulsification Cataract Surgery: Corneal And Foveal Changes. Investigative Ophthalmology & Visual Science. 2012;53:6640–6640.

Chatziralli IP, Kanonidou E, Kanonidou C, Chatzirallis A, Papazisis L. Central Serous Chorioretinopathy With Multiple Leakage Points in a Young Female Patient Without Detected Risk Factors. Journal of Medical Cases. 2012;3:201–203.

Papadopoulou D, Chatziralli IP, Papadopoulos V, Filitantzi C, Demertzidis C. Synchronous gastric inflammatory myofibroblastic tumour with gastrointestinal stromal tumour of the stomach and hepatic syringious haemangioma. Journal of surgical case reports. 2012;2012:7–7.

Moschos MM, Chatziralli IP, Siasou G, Papazisis L. Augenprobleme bei jungen Erwachsenen nach Computerbenutzung. Klinische Monatsblätter für Augenheilkunde. 2012;229:379–381.

Peponis VG, Chatziralli IP, Parikakis EA, Chaira N, Katzakis MC, Mitropoulos PG. Bilateral multifocal chorioretinitis and optic neuritis due to Epstein-Barr virus: a case report. Case reports in ophthalmology. 2012;3:327–332.

Chatziralli IP, Sergentanis TN, Kanonidou E, Papazisis L. First postoperative day review after uneventful phacoemulsification cataract surgery: Is it necessary?. BMC research notes. 2012;5:1–5.

Ladas ID, Chatziralli IP, Kotsolis AI, Douvali M, Georgalas I, Theodossiadis PG, Rouvas AA. Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration. Ophthalmologica. 2012;228:93–101.

Moschos MM, Chatziralli IP, Zagouri F, Zografos GC. Macular oedema due to letrozole: A first case report. Clinical and Experimental Optometry. 2012;95:646–650.

Moschos MM, Chatziralli IP, Pantazis P, Rouvas AA, Sergentanis TN. Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of ocular pharmacology and therapeutics. 2012;28:335–339.

Kanonidou E, Chatziralli IP, Konidaris V, Kanonidou C, Papazisis L. A comparative study of visual function of young myopic adults wearing contact lenses vs. spectacles. Contact Lens and Anterior Eye. 2012;35:196–198.

Ghorbanian S, Jaulim A, Chatziralli IP. Diagnosis and treatment of coats’ disease: a review of the literature. Ophthalmologica. 2012;227:175–182.

Moschos MM, Georgopoulos G, Chatziralli IP, Koutsandrea C. Multifocal VEP and OCT findings in patients with primary open angle glaucoma: a cross-sectional study. BMC ophthalmology. 2012;12:1–5.

Chatziralli IP, Sergentanis TN, Papazisis L, Moschos MM. Risk factors for intraoperative floppy iris syndrome: a retrospective study. Acta ophthalmologica. 2012;90:e152–e153.

Moschos MM, Chatziralli IP, Siasou G, Papazisis L. Visual problems in young adults due to computer use. Klin Monbl Augenheilkd. 2012;229:379–381.

Chatziralli IP, Moschos MM, Brouzas D, Kopsidas K, Ladas ID. Evaluation of retinal nerve fibre layer thickness and visual evoked potentials in optic neuritis associated with multiple sclerosis. Clinical and Experimental Optometry. 2012;95:223–228.

Chatziralli IP, Keryttopoulos P, Papazisis L, Moschos MM. Hypopyon in the context of tuberculous uveitis. Clinical and Experimental Optometry. 2012;95:241–243.

Rouvas AA, Chatziralli IP, Theodossiadis PG, Moschos MM, Kotsolis AI, Ladas ID. Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation. Retina. 2012;32:1181–1189.

Moschos MM, Markopoulos I, Chatziralli I, Rouvas A, Papageorgiou SG, Ladas I, Vassilopoulos D. Structural and functional impairment of the retina and optic nerve in Alzheimer's disease. Current Alzheimer Research. 2012;9:782–788.

Chatziralli IP, Kanonidou ED, Keryttopoulos P, Dimitriadis P, Papazisis LE. The value of fundoscopy in general practice. The open ophthalmology journal. 2012;6:4.

Sergentanis TN, Chatziralli IP. Floppy Iris Risk Factors reply. OPHTHALMOLOGY. 2011;118:2095–2095.

Chatziralli IP, others. Drug-induced lupus erythematosus with scleritis: case report. Reactions. 2011;1352:21.

Chatziralli IP, others. Irreversible optic neuropathy in an elderly patient: case report. Reactions. 2011;1352:21.

Kanonidou E, Chatziralli IP, Praidou A, Konidaris V. Contact lens usage characteristics among young individuals and their perception regarding future refractive surgery. Graefe's Archive for Clinical and Experimental Ophthalmology. 2011;249:307–308.

Chatziralli IP, Kanonidou E, Papazisis L. Frequency of fundus pathology related to patients’ dissatisfaction after phacoemulsification cataract surgery. Bull Soc Belge Ophtalmol. 2011;317:21–24.

Papadopoulou D, Chatziralli I, Filitatzi C, Demertzidis C. Primary retroperitoneal mucinous cystadenoma. Hippokratia. 2011;15:191.

Moschos MM, Brouzas D, Chatziralli IP, Ladas I. Ranibizumab in the treatment of choroidal neovascularisation due to age-related macular degeneration: an optical coherence tomography and multifocal electroretinography study. Clinical and Experimental Optometry. 2011;94:268–275.

Chatziralli IP, Kanonidou E, Chatzirallis A, Dimitriadis P, Keryttopoulos P. Episcleritis Related to Drug-Induced Lupus Erythematosus following Infliximab Therapy: A Case Report. Case reports in medicine. 2011;2011.

Chatziralli IP, Papazisis L, Sergentanis TN. Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica. 2011;225:89–94.

Chatziralli IP, Sergentanis TN. Risk factors for intraoperative floppy iris syndrome: a meta-analysis. Ophthalmology. 2011;118:730–735.

Moschos MM, Chatziralli IP, Sergentanis TN. Viscoat versus Visthesia during phacoemulsification cataract surgery: corneal and foveal changes. BMC ophthalmology. 2011;11:1–7.

Agorastos A, Vatkalis N, Kiryttopoulos P, Chatziralli I. IgE levels in rheumatoid arthritis differential diagnosis: 879. Allergy: European Journal of Allergy and Clinical Immunology. 2010;65.

Kiryttopoulos P, Agorastos A, Chatziralli I, Chatzis C, Dimitriadis P. Levels of beta tryptase in patients with skin allergy: 1154. Allergy: European Journal of Allergy and Clinical Immunology. 2010;65.

Kiryttopoulos P, Agorastos A, Ermidi E, Charalambidis M, Chatziralli I, Kaloutsi V. A rare case of mastocytosis: 910. Allergy: European Journal of Allergy and Clinical Immunology. 2010;65.

Kanonidou E, Chatziralli I, Kanonidou C, Parava M, Ziakas N. Unilateral optic disc edema in a paediatric patient: diagnostic dilemmas and management. Case reports in medicine. 2010;2010.

Chatziralli IP, Papazisis L, Keryttopoulos P, Papadopoulou D, Sergentanis TN. Disentangling renal function in the context of irreversible ethambutol optic neuropathy. International ophthalmology. 2010;30:743.

Chatziralli I, Kanonidou E, KANONIDOU C, Papazisis L. Comparative in vitro activity of fluoroquinolones against ocular coagulase-negative Staphylococcus species: a four-year study. Acta Ophthalmologica. 2010;88.

Chatziralli I, Kanonidou E, CHATZIRALLIS A, Papazisis L, SERGENTANIS T. First day post-operative review after uneventful phacoemulsification cataract surgery: is it necessary?. Acta Ophthalmologica. 2010;88.

Chatziralli IP, Kanonidou E, Keryttopoulos P, Papadopoulou D, Papazisis L. Graves’ ophthalmopathy misdiagnosed as relapsing conjunctivitis. Case reports in ophthalmology. 2010;1:53–55.

Chatziralli IP, Papazisis L, Sergentanis TN. Lidocaine 2% jelly versus lidocaine 2%-sodium hyaluronate 0.3% drops in phacoemulsification surgery. Graefe's Archive for Clinical and Experimental Ophthalmology. 2010;248:149–150.

Chatziralli IP, Sergentanis TN, Keryttopoulos P, Vatkalis N, Agorastos A, Papazisis L. Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC research notes. 2010;3:1–4.

Sergentanis TNT, Ntourakis D, Togia AN, Sindos MA, Sergentanis IN, Kabagiannis A, Chatziralli IP, Pyrros D. (92) Emergency Transport of Burn Injuries: The Case of Athens, Greece. Prehospital and Disaster Medicine. 2007;22:S52–S52.